These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9582756)

  • 21. Comparing peritonitis in continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients.
    Locatelli AJ; Marcos GM; Gómez MG; Alvarez SA; DeBenedetti LC
    Adv Perit Dial; 1999; 15():193-6. PubMed ID: 10682100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One nurse's experience. The development of CAPD dialysable dolls.
    Kennedy JM
    J Nephrol Nurs; 1985; 2(5):231-5. PubMed ID: 3850958
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of peritonitis in automated peritoneal dialysis patients.
    Diaz-Buxo JA
    Adv Perit Dial; 1998; 14():131-6. PubMed ID: 10649710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Auto-dialysis, a transfer of competence].
    Chatelin F; Renia C
    Soins; 2003 May; (675):40-2. PubMed ID: 12784477
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of the epidemiological, clinical and laboratory findings in continuous ambulatory peritoneal dialysis related peritonitis attacks].
    Bulut C; Oztürk R; Yilmaz GR; Parpucu H; Irmak H; Kinikli S; Duranay M; Demiröz AP
    Mikrobiyol Bul; 2008 Apr; 42(2):255-64. PubMed ID: 18697423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Encouraging adherence to treatment regimen in a CCPD patient.
    Swanson MC
    Nephrol Nurs J; 2004; 31(1):80. PubMed ID: 15008077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nutritional knowledge of a group of patients in continuous peritoneal dialysis].
    Protani M; Sansoni J
    Prof Inferm; 1997; 50(3):21-4. PubMed ID: 9653310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis.
    Siu YP; Leung KT; Tong MK; Kwan TH; Mok CC
    Nephrol Dial Transplant; 2005 Dec; 20(12):2797-802. PubMed ID: 16204302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A supportive partnership for CAPD patients.
    Warmington V; Baxter E
    Prof Nurse; 1996 Aug; 11(11):767-8. PubMed ID: 8718324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thirty years of universal home dialysis in Christchurch.
    McGregor D; Buttimore A; Robson R; Little P; Morton J; Lynn K
    N Z Med J; 2000 Feb; 113(1103):27-9. PubMed ID: 11482325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypokalaemia: an independent risk factor of Enterobacteriaceae peritonitis in CAPD patients.
    Chuang YW; Shu KH; Yu TM; Cheng CH; Chen CH
    Nephrol Dial Transplant; 2009 May; 24(5):1603-8. PubMed ID: 19103738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis.
    Montenegro J; Saracho R; Gallardo I; Martínez I; Muñoz R; Quintanilla N
    Nephrol Dial Transplant; 2007 Jun; 22(6):1703-8. PubMed ID: 17405794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and intraperitoneal proinflammatory cytokines profiles in patients on chronic peritoneal dialysis.
    Maksić D; Colić M; Stanković-Popović V; Radojević M; Bokonjić D
    Med Pregl; 2007; 60 Suppl 2():53-7. PubMed ID: 18928158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis.
    Coban E; Ozdogan M; Tuncer M; Bozcuk H; Ersoy F
    J Nephrol; 2004; 17(3):427-30. PubMed ID: 15365965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Training a continuous ambulatory peritoneal dialysis patient with one functional arm.
    Schuetz CE
    Adv Perit Dial; 2005; 21():146-7. PubMed ID: 16686306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of the earthquake in northwestern Turkey on the continuous ambulatory peritoneal dialysis patients who were living in the earthquake zone.
    Ozener C; Ozdemir D; Bihorac A
    Adv Perit Dial; 2000; 16():182-5. PubMed ID: 11045289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nitric oxide is a marker of peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Choi KC; Jeong TK; Lee SC; Kim SW; Kim NH; Lee KY
    Adv Perit Dial; 1998; 14():173-9. PubMed ID: 10649719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological and educational support for CAPD patients.
    Cook S
    Br J Nurs; 1995 Jul 27-Aug 9; 4(14):809-10, 827-8. PubMed ID: 7655273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.